Jak2 V617f Mutation

JAK2 V617F Mutation is a somatic gain-of-function point mutation in the Janus kinase 2 (JAK2) gene, characterized by a valine-to-phenylalanine substitution at position 617, that constitutively activates the JAK-STAT signaling pathway and is predominantly associated with the pathogenesis of classical BCR-ABL1–negative myeloproliferative neoplasms.

1K

Publications

76.7K

Citations

6.4K

Authors

1.6K

Institutions

Publications per year

2017–2026

247

Variants

Jak2 V617f

Authors

6.4K

  1. AT
    Ayalew Tefferi

    Mayo Clinic, United States

    64 publications · 8.5K citations

    40

    h-index

  2. AM
    Alessandro M. Vannucchi

    University of Florence, Italy

    35 publications · 3.9K citations

    32

    h-index

  3. PG
    Paola Guglielmelli

    University of Florence, Italy

    35 publications · 5.3K citations

    32

    h-index

  4. TL
    Terra L. Lasho

    Mayo Clinic, United States

    41 publications · 5.8K citations

    31

    h-index

  5. AP
    Animesh Pardanani

    Mayo Clinic in Arizona, United States

    45 publications · 5.4K citations

    30

    h-index

1–5 of 6.4K

Venues

  1. Blood

    139 publications · 19.6K citations

    74

    h-index

  2. Leukemia

    43 publications · 6.4K citations

    36

    h-index

  3. Haematologica

    45 publications · 2.7K citations

    31

    h-index

  4. British Journal of Haematology

    BJH · 46 publications · 3K citations

    29

    h-index

  5. American Journal of Hematology

    AJH · 34 publications · 1.6K citations

    23

    h-index

1–5